ISPOR 11th Annual
International Meeting
May 20-24, 2006
Marriott Philadelphia, Philadelphia, PA
RELEASED PRESENTATIONS
The ISPOR RESEARCH DIGEST is an electronic database of research papers presented at ISPOR Annual International Meetings, ISPOR Annual European Congresses, ISPOR Asia-Pacific and Latin America Conferences from 1998 to date. See: ISPOR Research Digest for contributed research podium and poster abstracts and released slide or poster presentations.
FIRST PLENARY SESSION
BALANCING AFFORDABILITY AND
VALUE: THE UNIVERSAL CHALLENGE IN HEALTH CARE DELIVERY
Leonard D. Schaeffer
Founding Chairman & CEO, WellPoint
BALANCING
AFFORDABILITY AND VALUE: THE UNIVERSAL CHALLENGE IN HEALTH CARE
DELIVERY OR
Evidence Evidence-based Decision Making in an Era of Cost Containment
Marc L. Berger, MD
Vice President, Outcomes Research & Management, Merck & Co., Inc.
SECOND PLENARY SESSION
COMPARATIVE EFFECTIVENESS & HEALTH CARE DECISION-MAKING
Joseph DiCesare, MPH, RPh
Head, Health Economics & Outcomes Research, Novartis Pharmaceuticals
Corp., East Hanover, NJ
EFFICIENCY, QUALITY AND COST IN HEALTH CARE
Harvey V. Fineberg , MD, PhD
President & Chair, Institute of Medicine, Washington, DC
THIRD PLENARY SESSION
THE PATIENT
VOICE IN MEDICAL PRODUCT EVALUATION: FDA DRAFT GUIDANCE ON MEASURING
PATIENT-REPORTED OUTCOMES
Laurie B Burke, RPh, MPH
Study Endpoints and Labeling, OND,
CDER, FDATHE PATIENT
VOICE IN MEDICAL PRODUCT EVALUATION: FDA DRAFT GUIDANCE ON MEASURING
PATIENT-REPORTED OUTCOMES - AN INDUSTRY PERSPECTIVE
Margaret L Rothman, PhD
Johnson & Johnson Pharmaceutical Services,
LLC
ISPOR PRO SIG
COMMENTS
Patrick Marquis, MD, MBA
Mapi Values, Boston
THE PATIENT
VOICE IN MEDICAL PRODUCT EVALUATION: FDA DRAFT GUIDANCE ON MEASURING
PATIENT-REPORTED OUTCOMES - COOPERATIVE SOLUTIONS
Nancy Kline Leidy PhD
Health Care Analytics Group, United BioSource
Corporation
11th Annual Meeting Main Page